Cellectar Biosciences Company Profile (NASDAQ:CLRB)

About Cellectar Biosciences

Cellectar Biosciences logoCellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., is a clinical stage biopharmaceutical company. The Company is engaged in developing phospholipid ether-drug conjugates (PDCs) for the treatment and diagnostic imaging of cancer. Its research and development program is based on its PDC cancer targeting delivery platform. Its pipeline consists of pre-clinical and clinical product candidates, including radiotherapeutic and chemotherapeutic PDC's. The Company's PDC product portfolio includes CLR 131, which is designed to deliver cytotoxic (cell-killing) radiation directly and selectively to cancer cells and cancer stem cells; CLR 125, which is for the treatment of micro metastatic disease; CLR 124, which is a cancer-targeting positron emission tomography (PET) imaging PDC; CLR 1502, which is for intraoperative tumor margin illumination and non-invasive tumor imaging, and CTX Product Portfolio, including CLR 1601-PTX, CLR 1602-PTX and CLR 1603-PTX product candidates.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CLRB
  • CUSIP:
Key Metrics:
  • Previous Close: $2.18
  • 50 Day Moving Average: $2.67
  • 200 Day Moving Average: $3.21
  • 52-Week Range: $1.00 - $32.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.63
  • P/E Growth: 0.00
  • Market Cap: $11.70M
  • Outstanding Shares: 5,368,000
  • Beta: 0.32
Additional Links:
Companies Related to Cellectar Biosciences:

Analyst Ratings

Consensus Ratings for Cellectar Biosciences (NASDAQ:CLRB) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cellectar Biosciences (NASDAQ:CLRB)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Cellectar Biosciences (NASDAQ:CLRB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/11/2016($0.40)($0.49)ViewN/AView Earnings Details
11/12/2015Q315($0.25)ViewListenView Earnings Details
8/12/2015Q215($0.30)ViewListenView Earnings Details
5/21/2015Q115($0.30)ViewListenView Earnings Details
3/26/2014($0.04)($0.05)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cellectar Biosciences (NASDAQ:CLRB)
Current Year EPS Consensus Estimate: $-0.80 EPS
Next Year EPS Consensus Estimate: $-0.83 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.40)($0.40)($0.40)
Q3 20161($0.20)($0.20)($0.20)
Q4 20161($0.20)($0.20)($0.20)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cellectar Biosciences (NASDAQ:CLRB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cellectar Biosciences (NASDAQ:CLRB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/20/2016James V CarusoCEOBuy46,948$2.12$99,529.76View SEC Filing  
4/20/2016Paul L BernsDirectorBuy117,371$2.12$248,826.52View SEC Filing  
12/31/2015Awm Investment Company, Inc.Major ShareholderSell100,000$0.69$69,000.00View SEC Filing  
12/29/2015Awm Investment Company, Inc.Major ShareholderSell82,847$0.69$57,164.43View SEC Filing  
12/28/2015Awm Investment Company, Inc.Major ShareholderSell367,966$0.73$268,615.18View SEC Filing  
12/22/2015Awm Investment Company, Inc.Major ShareholderSell7,938$0.90$7,144.20View SEC Filing  
12/21/2015Awm Investment Company, Inc.Major ShareholderSell27,621$0.92$25,411.32View SEC Filing  
12/17/2015Awm Investment Company, Inc.Major ShareholderSell71,225$0.87$61,965.75View SEC Filing  
12/15/2015Awm Investment Company, Inc.Major ShareholderSell44,965$0.82$36,871.30View SEC Filing  
12/4/2015Awm Investment Company, Inc.Major ShareholderSell50,950$1.06$54,007.00View SEC Filing  
11/24/2015Awm Investment Company, Inc.Major ShareholderSell173,802$1.24$215,514.48View SEC Filing  
11/24/2015James V CarusoCEOBuy1,000$1.30$1,300.00View SEC Filing  
11/20/2015Awm Investment Company, Inc.Major ShareholderSell96,806$1.17$113,263.02View SEC Filing  
11/20/2015James V CarusoCEOBuy1,000$1.16$1,160.00View SEC Filing  
11/19/2015James V. CarusoCEOBuy4,000$1.45$5,800.00View SEC Filing  
10/23/2015Awm Investment Company, Inc.Major ShareholderSell8,866$2.00$17,732.00View SEC Filing  
10/6/2015Awm Investment Company, Inc.Major ShareholderSell2,554$2.00$5,108.00View SEC Filing  
10/5/2015Awm Investment Company, Inc.Major ShareholderSell7,500$2.04$15,300.00View SEC Filing  
10/1/2015Awm Investment Company, Inc.Major ShareholderSell27,940$2.05$57,277.00View SEC Filing  
9/29/2015Awm Investment Company, Inc.Major ShareholderSell24,801$2.36$58,530.36View SEC Filing  
8/20/2014John NeisDirectorBuy268,711$3.75$1,007,666.25View SEC Filing  
8/20/2014Simon PedderCEOBuy13,300$3.75$49,875.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cellectar Biosciences (NASDAQ:CLRB)
DateHeadline
News IconCrowd Sentiment & Wall Street Views on Cellectar Biosciences, Inc. (NASDAQ:CLRB)? - Post News (NASDAQ:CLRB)
www.kentuckypostnews.com - August 23 at 8:26 AM
finance.yahoo.com logoCELLECTAR BIOSCIENCES, INC. Financials (NASDAQ:CLRB)
finance.yahoo.com - August 18 at 4:19 PM
finance.yahoo.com logoSeeThruEquity Issues Update on Cellectar Biosciences, Inc. (Nasdaq: CLRB) (NASDAQ:CLRB)
finance.yahoo.com - August 18 at 11:05 AM
News IconCellectar Biosciences Inc (NASDAQ:CLRB) Might Be Due A Bounce - Street Register (NASDAQ:CLRB)
streetregister.com - August 17 at 4:25 PM
News IconCellectar Biosciences Inc (NASDAQ:CLRB) Might Be Due A Bounce (NASDAQ:CLRB)
streetregister.com - August 17 at 11:17 AM
finance.yahoo.com logoEdited Transcript of CLRB earnings conference call or presentation 15-Aug-16 12:30pm GMT (NASDAQ:CLRB)
finance.yahoo.com - August 17 at 11:17 AM
News IconShares Trading Down in Session: Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Post News (NASDAQ:CLRB)
www.kentuckypostnews.com - August 16 at 9:31 PM
News IconCellectar Biosciences announces recent key accomplishments (NASDAQ:CLRB)
medicalphysicsweb.org - August 16 at 4:18 PM
publicnow.com logoCellectar Biosciences Announces Recent Key Accomplishments and Second Quarter 2016 Financial Results (NASDAQ:CLRB)
www.publicnow.com - August 11 at 10:05 PM
biz.yahoo.com logoCELLECTAR BIOSCIENCES, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:CLRB)
biz.yahoo.com - August 11 at 4:24 PM
publicnow.com logoCellectar Biosciences to Host Conference Call on August 15 to Report Second Quarter 2016 Financial Results and Corporate Performance (NASDAQ:CLRB)
www.publicnow.com - August 8 at 9:06 AM
streetinsider.com logoCellectar Biosciences (CLRB) Receives Multimillion Second Phase of NCI SBIR Contract for CLR 131 Phase 2 (NASDAQ:CLRB)
www.streetinsider.com - August 3 at 4:22 PM
streetinsider.com logoCellectar Biosciences (CLRB) Receives Multimillion Second Phase of NCI SBIR Contract for CLR 131 Phase 2 - StreetInsider.com (NASDAQ:CLRB)
www.streetinsider.com - August 3 at 11:35 AM
biz.yahoo.com logoCELLECTAR BIOSCIENCES, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant (NASDAQ:CLRB)
biz.yahoo.com - July 27 at 4:04 PM
News IconCellectar Biosciences, Inc. (NASDAQ:CLRB): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:CLRB)
www.engelwooddaily.com - July 22 at 11:46 AM
4-traders.com logoStockNewsNow.com : Publishes New SNNLive Video Interview with Cellectar Biosciences, Inc. Discussing Corporate Updates and Clinical Development (NASDAQ:CLRB)
www.4-traders.com - July 21 at 9:48 PM
finance.yahoo.com logoStockNewsNow.com Publishes New SNNLive Video Interview with Cellectar Biosciences, Inc. Discussing Corporate Updates and Clinical Development (NASDAQ:CLRB)
finance.yahoo.com - July 21 at 8:30 AM
News IconIncreased Stock Volatility Watch: Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Engelwood Daily (NASDAQ:CLRB)
www.engelwooddaily.com - July 20 at 5:24 PM
biz.yahoo.com logoCELLECTAR BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, (NASDAQ:CLRB)
biz.yahoo.com - July 20 at 4:03 PM
News IconCellectar Biosciences Incorporated (NASDAQ:CLRB) Sellers Covered 3.93% of Their Shorts - Consumer Eagle (NASDAQ:CLRB)
www.consumereagle.com - July 20 at 11:46 AM
News IconEquity Roundup: Stock Performance Focus on Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Press Telegraph (NASDAQ:CLRB)
presstelegraph.com - July 20 at 11:46 AM
finance.yahoo.com logoCellectar Biosciences Appoints Jarrod Longcor Senior Vice President of Corporate Development and Operations (NASDAQ:CLRB)
finance.yahoo.com - July 20 at 8:30 AM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Cellectar Biosciences, Inc. (NASDAQ:CLRB) - TGP (NASDAQ:CLRB)
telanaganapress.com - July 19 at 4:22 PM
News IconHeightened Volatility Spotted on Shares of: Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Engelwood Daily (NASDAQ:CLRB)
www.engelwooddaily.com - July 19 at 4:22 PM
News IconInvestor Watch: Volatility Recap on Shares of: Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Engelwood Daily (NASDAQ:CLRB)
www.engelwooddaily.com - July 19 at 4:22 PM
News IconIntraday Movers - Royal Dutch Shell, (NYSE:RDS-B), Cellectar Biosciences, (NASDAQ:CLRB) - Hot Stocks Point (NASDAQ:CLRB)
www.hotstockspoint.com - July 18 at 9:18 AM
finance.yahoo.com logoSeeThruEquity Initiates Coverage on Cellectar Biosciences, Inc. (NASDAQ: CLRB) with a Price Target of $7.44 (NASDAQ:CLRB)
finance.yahoo.com - July 18 at 9:00 AM
News IconShares Dipping Down in Today's Session: Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Telanagana Press (NASDAQ:CLRB)
telanaganapress.com - July 15 at 8:21 PM
News IconHC Stocks in Drift: Cellectar Biosciences Inc (NASDAQ:CLRB), Exelixis, Inc. (NASDAQ:EXEL) - share market updates (press release) (NASDAQ:CLRB)
sharemarketupdates.com - July 15 at 3:19 PM
News IconCellectar Biosciences, Inc. (NASDAQ:CLRB) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:CLRB)
www.engelwooddaily.com - July 14 at 9:43 PM
biz.yahoo.com logoCELLECTAR BIOSCIENCES, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements a (NASDAQ:CLRB)
biz.yahoo.com - July 14 at 12:00 AM
News IconCellectar Biosciences Incorporated (NASDAQ:CLRB) Short Interest Decreased By 56.47% - Consumer Eagle (NASDAQ:CLRB)
www.consumereagle.com - July 13 at 9:39 PM
News IconCellectar Biosciences, Inc. (NASDAQ:CLRB) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:CLRB)
telanaganapress.com - July 12 at 4:21 PM
News IconHeightened Volatility Check on: Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Engelwood Daily (NASDAQ:CLRB)
www.engelwooddaily.com - July 7 at 4:17 PM
kcregister.com logoBest Stocks: Cellectar Biosciences, (NASDAQ:CLRB), LinkedIn Corporation (NYSE:LNKD), New York & Company ... - KC Register (NASDAQ:CLRB)
www.kcregister.com - July 5 at 9:00 AM
News IconUpdate on Stock Volatility for: Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Engelwood Daily (NASDAQ:CLRB)
www.engelwooddaily.com - July 1 at 12:07 PM
biz.yahoo.com logoCELLECTAR BIOSCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:CLRB)
biz.yahoo.com - June 30 at 4:30 PM
4-traders.com logoTESARO : Why Investors Love These Biotech's Stocks? - Cellectar Biosciences, Xenoport, Rexahn Pharma, and Tesaro (NASDAQ:CLRB)
www.4-traders.com - June 29 at 12:21 PM
kcregister.com logoMorning Watch List: Cartesian, Inc. (NASDAQ:CRTN), Cellectar Biosciences, Inc. (NASDAQ:CLRB), Comerica ... - KC Register (NASDAQ:CLRB)
www.kcregister.com - June 27 at 4:17 PM
wallstrt24.com logoMylan NV (NASDAQ:MYL) & Cellectar Biosciences (NASDAQ:CLRB) are Hot Healthcare Stocks - Wall Street 24 (NASDAQ:CLRB)
wallstrt24.com - June 25 at 8:07 AM
streetinsider.com logoCellectar Biosciences (CLRB) Announces Significant Data from NCI-Sponsored CLR 125 Phase 1 in TNBC (NASDAQ:CLRB)
www.streetinsider.com - June 24 at 4:22 PM
News IconCellectar Biosciences, Inc. (NASDAQ:CLRB) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:CLRB)
www.engelwooddaily.com - June 24 at 8:01 AM
News IconActive Stocks on Frontline- Teva Pharmaceutical (NYSE:TEVA), Cellectar Biosciences (CLRB), Hertz Global (NYSE:HTZ) - Seneca Globe (NASDAQ:CLRB)
www.senecaglobe.com - June 24 at 8:01 AM
streetinsider.com logoCellectar Biosciences (CLRB) Announces Significant Data from NCI-Sponsored CLR 125 Phase 1 in TNBC - StreetInsider.com (NASDAQ:CLRB)
www.streetinsider.com - June 23 at 5:45 PM
benzinga.com logoMid-Morning Market Update: Markets Open Higher; BlackBerry Profit Tops Views (NASDAQ:CLRB)
www.benzinga.com - June 23 at 11:13 AM
publicnow.com logoCellectar Biosciences Announces Results of NCI-Sponsored Study of CLR 125 Showing Potential Effect Against Triple Negative Breast Cancer (NASDAQ:CLRB)
www.publicnow.com - June 23 at 8:49 AM
istreetwire.com logoCellectar Biosciences, Inc. (NASDAQ:CLRB) Earns Consensus Hold Rating - iStreetWire (NASDAQ:CLRB)
istreetwire.com - June 17 at 4:07 PM
News IconMost Volatile Healthcare Movers- Exact Sciences (NASDAQ:EXAS), Cellectar Biosciences (NASDAQ:CLRB) - Seneca Globe (NASDAQ:CLRB)
www.senecaglobe.com - June 17 at 4:07 PM
News IconEarnings Overview: Neovasc Inc. (NASDAQ:NVCN), Cellectar Biosciences, Inc. (NASDAQ:CLRB) - Beacon Chronicle (NASDAQ:CLRB)
www.beaconchronicle.com - June 17 at 4:07 PM
rttnews.com logoCellectar Biosciences Inc. (CLRB) Climbed On Study Results - RTT News (NASDAQ:CLRB)
www.rttnews.com - June 17 at 4:07 PM

Social

Cellectar Biosciences (NASDAQ:CLRB) Chart for Thursday, September, 1, 2016


Last Updated on 9/1/2016 by MarketBeat.com Staff